[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"radiology-interventional\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:radiology-interventional":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,51,83,113],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100644014","a-study-of-the-impact-of-a-virtual-reality-medical-device-hypnovr-headset-on-anxiety-and-pain-in-interventional-radiology-100644014",false,"NCT07668050","A Study of the Impact of a Virtual Reality Medical Device (HypnoVR® Headset) on Anxiety and Pain in Interventional Radiology.","HYPNO-VR","Inclusion Criteria :\n\n* Age ≥18 years.\n* Scheduled to undergo an interventional radiology procedure performed under local anesthesia without sedation.\n* Affiliation to a health insurance system.\n* Received complete information about the study and provided written informed consent.\n* Ability to understand the study information and complete the questionnaires.\n\nExclusion Criteria :\n\n* Refusal to participate or withdrawal of consent.\n* Patients under legal protection preventing valid informed consent according to regulatory requirements.\n* Inability to understand study-related information or to use the virtual reality device due to severe visual, auditory, or cognitive impairment, as clinically assessed by the investigator.\n* History of photosensitive epilepsy or uncontrolled epilepsy, constituting a contraindication to virtual reality use.\n* Known contraindication to virtual reality use (history of severe cybersickness).","ALL","18 Years",{"count":19,"type":20},70,"ESTIMATED","INTERVENTIONAL",[23],"NA","Patients undergoing interventional radiology procedures frequently experience significant anxiety and procedural pain despite standard care. Virtual reality (VR) has emerged as a promising non-pharmacological tool for anxiety and pain reduction in various medical settings.\n\nThe HYPNO-VR study is a prospective randomized controlled trial designed to evaluate the effect of immersive virtual reality during interventional radiology procedures. Participants will be randomized in a 1:1 ratio to either a virtual reality group or a standard care control group.\n\nThe primary objective is to assess the impact of VR on procedural anxiety and pain using validated anxiety questionnaires (State-Trait Anxiety Inventory, STAI) and a numerical pain rating scale.\n\nSecondary and exploratory objectives include assessment of patient satisfaction, operator experience, procedural duration, analgesic use, and feasibility of VR integration in interventional radiology practice.",[26,27,28],"Anxiety","Pain","Radiology, Interventional",[30,31,32,33,34,35,36,37],"Virtual Reality","Interventional Radiology","State-Trait Anxiety Inventory","Patient Satisfaction","Non-pharmacological Intervention","Immersive Virtual Reality","Procedural Anxiety","Procedural Pain","NOT_YET_RECRUITING","2026-06-25",{"date":41,"type":42},"2026-06-29","ACTUAL",{"date":44,"type":20},"2026-06",{"date":46,"type":20},"2026-12",{"name":48,"class":49},"University Hospital, Clermont-Ferrand","OTHER",1,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":16,"minAge":17,"maxAge":60,"enrollmentInfo":61,"targetDuration":4,"studyType":21,"phases":63,"briefSummary":64,"conditions":65,"keywords":69,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":50},"100542231","ct-guided-lung-biopsy-risk-optimization-method-100542231","NCT06340178","CT-guided Lung Biopsy Risk Optimization Method","CT-guided Lung Biopsy Risk Optimization Method - Effect of Fluid Application in the Pleural Cavity and the Gravitational Effect of Pleural Pressure","BROM-I","Inclusion Criteria:\n\n* Ability to provide informed consent (knowledge of project languages), \\>18 years.\n* Indeterminate or suspicious lung lesion unsuitable for transbronchial biopsy or Status after unsuccessful transbronchial biopsy\n* Indication for biopsy given by referring specialist (in patients).\n\nExclusion Criteria:\n\n* Preintervention bleeding into the pleural cavity\n* More than 1 lesion should be biopsied at the same time\n* Infiltration of the thoracic wall\n* Pregnancy",true,"100 Years",{"count":62,"type":20},198,[23],"The purpose of this randomized controlled study is to evaluate the extent to which injection of a small amount of fluid in the pleural cavity at the biopsy site may reduce the risk of pneumothoraces, in addition to patient positioning to allow biopsy in gravity-dependent areas of the lung.",[66,67,68,28],"Pneumothorax","Biopsy, Needle","Risk Factors",[70,68,71,72,66],"Image-Guided Biopsy","Tomography","Biopsy","RECRUITING","2026-01-29",{"date":76,"type":42},"2026-02-02",{"date":78,"type":42},"2025-09-29",{"date":80,"type":20},"2027-04-01",{"name":82,"class":49},"Insel Gruppe AG, University Hospital Bern",{"id":84,"slug":85,"hasResults":11,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":89,"eligibilityCriteria":90,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":91,"targetDuration":4,"studyType":21,"phases":93,"briefSummary":94,"conditions":95,"keywords":99,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":50},"100574698","radiology-consultation-effectiveness-100574698","NCT06762665","RAdiology Consultation Effectiveness","Impact of Interventional Radiology Consultation on the Spinal Infiltrations Effectiveness","RACE","Inclusion Criteria:\n\n* Patient 18 years of age or older\n* Referred to the imaging department for a peri-spinal injection under CT guidance.\n* Low back pain, dorsal pain, or neck pain with an average pain intensity of ≥ 5\u002F10 on NPRS.\n\nExclusion Criteria:\n\n* Patient unable to read and\u002For write French\n* Patient unable to condut a teleconsultation (no phone, no internet connection)\n* Current pregnancy, breastfeeding, or lack of effective contraception for women of childbearing age\n* Lack of consent\n* Legally protected population:\n\n  * Adults protected by law (guardianship, curatorship, or judicial protection)\n  * Non-emancipated minors\n  * Individuals unable to express consent (research conducted in emergency situations)\n  * Individuals deprived of liberty (by judicial or administrative decision, or involuntary hospitalization)\n* Not affiliated with a social security scheme or not benefiting from such a scheme\n* Participation in another research study with an ongoing exclusion period",{"count":92,"type":20},270,[23],"Performing a consultation with the radiologist before a spinal invasive procedure serves to foster a trusting physician-patient relationship. It also provides an opportunity for the comprehensive explanation of the procedure, its aftermath, and any patient inquiries. We believe that this proactive approach has the potential to alleviate pre-procedure anxiety, thereby contributing to an enhanced overall experience of the intervention and its outcomes. Despite these potential benefits, it is noteworthy that such consultations are not systematically implemented, and their impact on the intervention effictness remains unexplored in existing literature.\n\nThe hypothesis is grounded in the belief that patients who perform a consultation preceding their spinal intervention are likely to witness improvements in both the overall experience of the procedure and its effectiveness.",[96,97,98],"Radiology Interventional","Spinal Injections","Back Pain",[100,101,102,97,103],"Consultation","Remote consultation","Radiology interventional","Health care","2025-03-17",{"date":106,"type":42},"2025-03-20",{"date":108,"type":42},"2025-02-12",{"date":110,"type":20},"2027-09-01",{"name":112,"class":49},"University Hospital, Montpellier",{"id":114,"slug":115,"hasResults":11,"nctId":116,"briefTitle":117,"officialTitle":118,"acronym":119,"eligibilityCriteria":120,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":121,"targetDuration":123,"studyType":124,"phases":4,"briefSummary":125,"conditions":126,"keywords":4,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":128,"lastUpdatePostDateStruct":129,"startDateStruct":131,"completionDateStruct":133,"leadSponsor":135,"locationsCount":50},"100555053","dosimetric-reference-levels-for-radioguided-interventional-procedures-in-rhythmology-100555053","NCT06507085","Dosimetric Reference Levels for Radioguided Interventional Procedures in Rhythmology.","Dosimetric Reference Levels for Radioguided Interventional Procedures in Rhythmology. The NR-Rythmo Study","NR-Rythmo","Inclusion Criteria:\n\n* Adult male\u002Ffemale patient (≥ 18 years)\n* Body Mass Index (BMI) between 18 and 35 kg\u002Fm².\n* Patient to benefit from one of the following procedures:\n\nPlacement of single-chamber pacemaker with lead (DELF 007 according to CCAM) Dual-chamber pacemaker insertion with lead (DELF 005 according to CCAM) Multi-site pacemaker placement (DELF 001 and\u002For DELF 015 according to CCAM) Placement of single-chamber endovascular defibrillator (DELF 013 according to CCAM) Placement of dual-chamber endovascular defibrillator (DELF 015 according to CCAM) Placement of multi-site defibrillator (DELF 020 or DELF 014 according to CCAM) Primo Ablation Typical Atrial Flutter: Cavotricuspid Isthmus only (DEPF 012 according to CCAM) Primo Ablation tachycardia by intra nodal re-entry (DEPF 010 according to CCAM) Accessory pathway ablation (DEPF 005 according to CCAM) Paroxysmal atrial fibrillation ablation (4 pulmonary veins only, all technologies combined; DEPF 033 as per CCAM) Primo Ablation Persistent atrial fibrillation (4 pulmonary veins ± lines ± substrate; DEPF 033 ± DEPF 014 ± DENF 018 ± DEPF 012 according to CCAM)\n\nExclusion Criteria:\n\n* Patient whose procedure does not require X-rays\n* Pregnant women",{"count":122,"type":20},6600,"12 Months","OBSERVATIONAL","Interventional radiology has become a widespread technique used in various fields of medicine to diagnose or treat numerous pathologies. However, the risk of X-rays must be taken into account. In 2019, the French Authority on Nuclear Safety published diagnostic reference levels for radio-guided interventional practices for 10 interventional radiology procedures and 2 interventional cardiology procedures, based on studies published by the French Society of Medical Physics in collaboration with the French Society of Radiology and the French Coronary Artery Disease and Interventional Cardiology Group. Reference levels for interventional procedures under CT guidance were also defined in 2020 following a national multicenter study coordinated by Nîmes University Hospital (NIMAO NRD-SI). However, no national multicentre studies have ever defined reference levels for radioguided interventional procedures in rhythmology. The aim of this study is to define standard national dosimetric levels for a number of radioguided interventional procedures in rhythmology.",[28,127],"Heart Rhythm Disorders","2024-07-11",{"date":130,"type":42},"2024-07-18",{"date":132,"type":42},"2024-05-01",{"date":134,"type":20},"2026-01-01",{"name":136,"class":49},"Centre Hospitalier Universitaire de Nīmes"]